Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Prostate Cancer”

856 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 856 results

Testing effectiveness (Phase 2)Study completedNCT03322020
What this trial is testing

Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer

Who this might be right for
Neoplasm, Prostate
Asan Medical Center 30
Not applicableLooking for participantsNCT04945642
What this trial is testing

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more
Jonsson Comprehensive Cancer Center 52
Large-scale testing (Phase 3)Looking for participantsNCT06565247
What this trial is testing

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Who this might be right for
Prostate Cancer
Region Västerbotten 60
Not applicableUnknownNCT03253978
What this trial is testing

SPORT High-Risk Trial Evaluating SABR in Prostate Cancer

Who this might be right for
Prostate Cancer
Belfast Health and Social Care Trust 40
Testing effectiveness (Phase 2)Looking for participantsNCT04989946
What this trial is testing

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 60
Not applicableStudy completedNCT00176579
What this trial is testing

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Who this might be right for
OsteoporosisProstate Cancer
University of Medicine and Dentistry of New Jersey 27
Testing effectiveness (Phase 2)Study completedNCT01696877
What this trial is testing

A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer

Who this might be right for
Prostate Cancer Adenocarcinoma in Situ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 29
Post-approval studies (Phase 4)Study completedNCT01753297
What this trial is testing

Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

Who this might be right for
Prostate Cancer
Ipsen 226
Not applicableActive Not RecruitingNCT03822494
What this trial is testing

CyberKnife Dose Escalation Prostate Cancer Trial

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm
Crozer-Keystone Health System 100
Large-scale testing (Phase 3)Looking for participantsNCT06650579
What this trial is testing

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Who this might be right for
Recurrent Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
Emory University 72
Large-scale testing (Phase 3)Study completedNCT00056407
What this trial is testing

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 8,231
Testing effectiveness (Phase 2)Study completedNCT02280356
What this trial is testing

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 45
Not applicableStudy completedNCT04015102
What this trial is testing

A Registry for Hereditary Cancer Risk Assessment and Genetic Testing

Who this might be right for
Prostate Cancer
Myriad Genetic Laboratories, Inc. 255
Large-scale testing (Phase 3)UnknownNCT01398657
What this trial is testing

Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 182
Not applicableStudy completedNCT01962324
What this trial is testing

Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer

Who this might be right for
Prostatic NeoplasmsLymphatic Metastasis
Umeå University 85
Not applicableLooking for participantsNCT06949254
What this trial is testing

PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial

Who this might be right for
High Risk Prostate Cancer
Istituto Clinico Humanitas 49
Not applicableLooking for participantsNCT07407608
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0

Who this might be right for
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic
University of Milano Bicocca 58
Not applicableStudy completedNCT01499381
What this trial is testing

EMBRACE1: Prostate Biorepository

Who this might be right for
Prostate Cancer
Caris Science, Inc. 1,290
Testing effectiveness (Phase 2)Ended earlyNCT02508636
What this trial is testing

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

Who this might be right for
Prostatic NeoplasmsPelvic Nodal
University of California, San Francisco 11
Large-scale testing (Phase 3)Active Not RecruitingNCT02446444
What this trial is testing

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University of Sydney 802
Load More Results